You are using an outdated browser. Please
upgrade your browser to improve your experience.
The TOMORROW study AC-055-312 engagement App has been developed to engage patients in the event-driven study to assess efficacy, safety and pharmacokinetics of macitentan versus standard of care in children with pulmonary arterial hypertension
PPD TOMORROW
by Exco InTouch
What is it about?
The TOMORROW study AC-055-312 engagement App has been developed to engage patients in the event-driven study to assess efficacy, safety and pharmacokinetics of macitentan versus standard of care in children with pulmonary arterial hypertension.
App Store Description
The TOMORROW study AC-055-312 engagement App has been developed to engage patients in the event-driven study to assess efficacy, safety and pharmacokinetics of macitentan versus standard of care in children with pulmonary arterial hypertension.
The App will look to engage patients registered into this study.
*Note: this App requires an activation code and can only be accessed by patients who are participating in the AC-055-312 trial.
“This app is to support an approved observational research study.”
Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
